Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-03-06, Stock:NVS, The news for the past five days is as follows:
2019-02-27: NEWS1: Trump ex-lawyer Cohen: drugmaker Novartis wanted him to lobby, he refused.NEWS2: Ophthotech's (OPHT) Q4 Loss Wider, Gene Therapy in Focus.NEWS3: Ophthotech's (OPHT) Q4 Loss Wider, Gene Therapy in Focus.NEWS4: Trump's ex-lawyer Cohen: drugmaker Novartis wanted him to lobby, but he declined.NEWS5: Trump's ex-lawyer Cohen: drugmaker Novartis wanted him to lobby, but he declined.NEWS6: A Look at Spark’s Potential Revenue Contribution to Roche Holdings.NEWS7: Ophthotech's (OPHT) Q4 Loss Wider, Gene Therapy in Focus.NEWS8: [$$] Blackstone Life Sciences, Novartis to Launch Cardiovascular Drug Company.NEWS9: [$$] Blackstone Life Sciences and Novartis to Launch Cardiovascular Drug Company.NEWS10: Akcea Therapeutics, Inc. (AKCA) Q4 2018 Earnings Conference Call Transcript.
2019-02-28: NEWS1: Aduro (ADRO) Q4 Earnings and Revenues Fall Shy of Estimates.NEWS2: Aduro (ADRO) Q4 Earnings and Revenues Fall Shy of Estimates.NEWS3: Aduro (ADRO) Q4 Earnings and Revenues Fall Shy of Estimates.NEWS4: Momenta Continues to Rebuild.NEWS5: Momenta Continues to Rebuild.NEWS6: Novartis faces shareholder criticism over drug prices at AGM.NEWS7: Novartis faces shareholder criticism over drug prices at AGM.NEWS8: Ionis Pharmaceuticals (IONS) Q4 2018 Earnings Conference Call Transcript.
2019-03-01: NEWS1: Novartis AG (NVS) Ex-Dividend Date Scheduled for March 04, 2019.NEWS2: Novartis AG (NVS) Ex-Dividend Date Scheduled for March 04, 2019.NEWS3: Novartis’ CEO is “un-bossing” his 125,000 employees.
2019-03-04: NEWS1: Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates.
2019-03-05: NEWS1: FDA&apos;s Scott Gottlieb Resigns — What&apos;s Next For Biotech, Pharma?.NEWS2: Novartis has no plans to sell Sandoz - chairman.NEWS3: The Daily Biotech Pulse: Novartis Psoriasis Drug Found Superior, Ascendis Offering, Adamas Earnings.

Answer: Rise